Profil
Pavan Cheruvu served as the Chief Executive Officer at Sio Gene Therapies, Inc. and Axovant Sciences, Inc. He received his undergraduate degree from Duke University, graduate degree from the University of Oxford, and doctorate from Harvard Medical School.
Anciens postes connus de Pavan Cheruvu
| Sociétés | Poste | Fin |
|---|---|---|
| SIO GENE THERAPIES INC. | Chief Executive Officer | 31/01/2022 |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Chief Executive Officer | 01/12/2020 |
Formation de Pavan Cheruvu
| Duke University | Undergraduate Degree |
| University of Oxford | Graduate Degree |
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
